Skip to Content
MilliporeSigma
All Photos(1)

Key Documents

360171

Sigma-Aldrich

Potassium citrate tribasic monohydrate

≥99%

Synonym(s):

Citric acid tripotassium salt, Tripotassium citrate

Sign Into View Organizational & Contract Pricing


About This Item

Linear Formula:
HOC(COOK)(CH2COOK)2 · H2O
CAS Number:
Molecular Weight:
324.41
Beilstein/REAXYS Number:
3924344
EC Number:
MDL number:
UNSPSC Code:
12161700

assay

≥99%

mp

275 °C (dec.) (lit.)

SMILES string

O.[K+].[K+].[K+].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O

InChI

1S/C6H8O7.3K.H2O/c7-3(8)1-6(13,5(11)12)2-4(9)10;;;;/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);;;;1H2/q;3*+1;/p-3

InChI key

PJAHUDTUZRZBKM-UHFFFAOYSA-K

Looking for similar products? Visit Product Comparison Guide

replaced by

Product No.
Description
Pricing

Storage Class

13 - Non Combustible Solids

wgk_germany

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)


Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Clay Mechlin et al.
Journal of endourology, 25(9), 1541-1545 (2011-08-06)
Oral citrate supplements have been shown to decrease kidney stone recurrence rates in both laboratory and clinical studies. The taste of the citrate supplements, however, is poor, and long-term compliance is low. Our objective was to determine if Splenda(®) added
Chao-Yang Duan et al.
International journal of nanomedicine, 8, 909-918 (2013-03-08)
The property changes of urinary nanocrystallites in 13 patients with calcium oxalate (CaOx) stones were studied before and after ingestion of potassium citrate (K3cit), a therapeutic drug for stones. The analytical techniques included nanoparticle size analysis, transmission electron microscopy, X-ray
Donna J Claes et al.
Pediatric nephrology (Berlin, Germany), 27(11), 2031-2038 (2012-01-28)
Cystinuria is a relatively uncommon cause of pediatric stone disease, but has significant morbidity if not properly controlled because of its significant stone recurrence rate. Cystinuria is caused by the inability of the renal tubules to reabsorb filtered cystine, which
B Lojanapiwat et al.
International braz j urol : official journal of the Brazilian Society of Urology, 37(5), 611-616 (2011-11-22)
To evaluate the preventive effects of alkaline citrate on stone recurrence as well as stone growth post-ESWL or PCNL in patients with calcium-containing stones. A total of 76 patients with calcium calculi who were stone-free or had residual stones less
Pierre Cochat et al.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 27(5), 1729-1736 (2012-05-02)
Primary hyperoxaluria Type 1 is a rare autosomal recessive inborn error of glyoxylate metabolism, caused by a deficiency of the liver-specific enzyme alanine:glyoxylate aminotransferase. The disorder results in overproduction and excessive urinary excretion of oxalate, causing recurrent urolithiasis and nephrocalcinosis.

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service